Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Studies how childhood adversity relates to life quality in multiple sclerosis

Observes whether difficult childhood experiences affect adults living with multiple sclerosis.

Plain-language title generated from the registry record
Registry title: Adverse Childhood Experiences in Patients With MS: Impact on Quality of Life and on Coping Strategies Towards the Disease and Its Treatment

Key facts

Where
Rome, ItalySee the site

Where in Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCSRome, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Trial code
NCT06718920
Record updated
26 February 2025
Original description
The goal of this observational study is to evaluate the presence of adverse childhood experiences (ACE) in patients with Multiple Sclerosis. The main questions it aims to answer are:Read full original descriptionShow less

Single-center Observational Study to Characterize Adverse Childhood Experiences (ACE) in Patients With Multiple Sclerosis and Their Impact on Quality of Life, Disease Coping Strategies, and Adherence to Disease Course-modifying Therapies

The goal of this observational study is to evaluate the presence of adverse childhood experiences (ACE) in patients with Multiple Sclerosis. The main questions it aims to answer are:

* Does the presence of ACE impact on quality of life of patients with multiple sclerosis? * Does it influence how the patients cope with the disease and with disease course-modifying therapies? During follow up visits, planned as part of their regular medical care, participants will answer survey questions on a tablet .

Inclusion: Age older than 18 years; Diagnosis of relapsing-remitting multiple sclerosis according to McDonald criteria (2017 revisions) made between 2014 and 2024; Signature of informed consent.

Exclusion: Presence of conditions that prevent or limit understanding and proper completion of questionnaires; Presence of language barrier.

ClinicalTrials.gov NCT06718920